Winkelmann Carolin, Neumann Thomas, Zeidler Jan, Prenzler Anne, Vogt Bodo, Wacker Frank K
Chair in Empirical Economics, Otto-von-Guericke-University Magdeburg, Germany.
Research Campus STIMULATE, Otto-von-Guericke-University Magdeburg, Germany.
Rofo. 2019 Jul;191(7):635-642. doi: 10.1055/a-0838-6253. Epub 2019 Feb 14.
Health technology assessments (HTAs) are an interdisciplinary method to support sustainable, evidence-based healthcare decisions. They systematically assess medical products, procedures, and technologies with respect to medical, economic, legal, social, and ethical aspects.
This review analyzes the current use of HTAs in radiology in Germany and discusses challenges associated with HTAs. In particular, incentive structures of various players in the healthcare field involved in HTA implementation are considered for both the inpatient and outpatient sectors. Taking into account that the Joint Federal Committee (G-BA) has different authority between sectors ("ban reservation" for inpatients and "authorization right" for outpatients), we focus on the repercussions on reimbursement for new diagnosis or treatment methods by statutory health insurance companies.
The G-BA's authority implicitly creates a paradox in terms of incentives to implement and finance HTAs: in the outpatient sector HTAs are considered necessary to evaluate new medical services while players may not have sufficient incentive to implement and finance HTAs in the inpatient sector.
Characteristics of HTAs differ widely with respect to the items to be assessed. Therefore, an HTA for drug effectiveness is not easily transferable to radiological procedures. Within radiology, each method must be assessed individually (e. g. according to tumor stage). Despite these challenges, systematic compilation and critical assessment (regarding both cost and medical effectiveness) of available evidence should be a basic component of evidence-based radiology. As companies in healthcare fail to invest in studies that advance evidence-based radiology and considering the lack of incentive for such investments, public funding institutions need to accept the challenge to support studies that assess the benefit of radiological procedures.
· HTAs should be a basic component of evidence-based radiology.. · G-BA's authority implicitly creates a paradox in terms of inventives to implement and finance HTAs.. · University hospitals and public funding institutions need to support studies that assess the benefit of radiological procedures..
· Winkelmann C, Neumann T, Zeidler J et al. Health Technology Assessments in Radiology in Germany: Lack of Demand, Lack of Supply. Fortschr Röntgenstr 2019; 191: 635 - 642.
卫生技术评估(HTA)是一种跨学科方法,用于支持可持续的、基于证据的医疗保健决策。它从医学、经济、法律、社会和伦理等方面系统地评估医疗产品、程序和技术。
本综述分析了德国放射学领域HTA的当前使用情况,并讨论了与HTA相关的挑战。特别是,考虑到参与HTA实施的医疗保健领域各参与者的激励结构,涵盖了住院和门诊部门。鉴于联邦联合委员会(G-BA)在不同部门有不同的权力(住院患者为“禁止保留”,门诊患者为“授权权”),我们重点关注法定健康保险公司对新诊断或治疗方法报销的影响。
G-BA的权力在实施和资助HTA的激励方面隐含地造成了一个悖论:在门诊部门,HTA被认为是评估新医疗服务所必需的,而在住院部门,参与者可能没有足够的动力来实施和资助HTA。
HTA在待评估项目方面差异很大。因此,药物疗效的HTA不易转化为放射学程序。在放射学领域,每种方法都必须单独评估(例如根据肿瘤分期)。尽管存在这些挑战,但对现有证据进行系统整理和批判性评估(包括成本和医疗效果)应是循证放射学的基本组成部分。由于医疗保健领域的公司未能投资于推进循证放射学的研究,且考虑到缺乏此类投资的激励,公共资助机构需要接受挑战,支持评估放射学程序益处的研究。
· HTA应是循证放射学的基本组成部分。· G-BA的权力在实施和资助HTA的激励方面隐含地造成了一个悖论。· 大学医院和公共资助机构需要支持评估放射学程序益处的研究。
· Winkelmann C, Neumann T, Zeidler J等。德国放射学中的卫生技术评估:需求不足,供应不足。Fortschr Röntgenstr 2019; 191: 635 - 642。